http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100732692-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate | 2000-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100732692-B1 |
| titleOfInvention | Cyclothiocarbamate Derivatives, Progesterone Receptor Regulators |
| abstract | The present invention provides compounds or pharmaceutically acceptable salts thereof, which are agonists of progesterone receptors and have the following structural formulas (I) or (II), as well as methods of using these compounds for the treatment of contraception and progesterone-related diseases: do.n n n n n n n n Wheren n n R 1 and R 2 are H, optionally substituted C 1 to C 6 alkyl, alkenyl, alkynyl groups, C 3 to C 8 cycloalkyl, aryl, substituted aryl, or heterocyclic groups, COR A , or NR B An independent substituent selected from the group of COR A ; Or R 1 and R 2 are fused by fused optionally substituted 3-8 membered spirocyclic alkyl or alkenyl rings or 1-3 heteroatoms selected from O, S and N; R A is selected from H, amino, or optionally substituted C 1 to C 3 alkyl, aryl, C 1 to C 3 alkoxy, or C 1 to C 3 aminoalkyl groups; R B is H, C 1 to C 3 alkyl, or substituted C 1 to C 3 alkyl; R 3 is H, OH, NH 2 , COR C , optionally substituted C 1 to C 6 alkyl, C 1 to C 6 alkenyl or alkyne diary; R C is selected from H, optionally substituted C 1 to C 3 alkyl, aryl, substituted aryl, C 1 to C 3 alkoxy, or C 1 to C 3 aminoalkyl groups; Q 1 is S, NR 7 , or CR 8 R 9 ; Or CR 8 R 9 is an optionally trisubstituted benzene ring having 1, 2 or 3 heteroatoms selected from the group of O, S, SO, SO 2 or NR 6 or an optionally substituted 5 or 6 membered heterocycle .n n n Progesterone, progesterone receptor, agonist, contraception, cyclothiocarbamate |
| priorityDate | 1999-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.